Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.
The Lexington addicts, 1971-1972: demographic characteristics, drug use patterns, and selected infectious disease experience.
Int J Addict. 1989 Jul;24(7):609-26. Unique Identifier : AIDSLINE MED/90093544 Lange WR; Ball JC; Pfeiffer MB; Snyder FR; Cone EJ; Addiction Research Center, National Institute on Drug Abuse,; Baltimore, Maryland.
Abstract:
The demographics, drug habits, and medical complications of a cohort of 1,129 addicts treated at Lexington in the period 1971-1972 were studied. These patients, admitted from 41 different states, had a mean period of addiction of 5.4 years. Over one-third of the sample had engaged in pimping or prostitution, and there were no differences by gender in terms of involvement. Eight-eight percent had shared injection equipment, and surprisingly, 78% admitted to some effort at sterilizing their works. Hepatitis was the most common associated medical condition: 87% had serologic markers of hepatitis B virus (HBV) infection, 60% had evidence of hepatitis A virus (HAV) exposure, and 47% had abnormal liver function parameters. Gynecomastia was evident in 2% of male subjects. Thirteen percent of the sample had a reactive VDRL assay, but 64% of these were biologically false positive. Subtle abnormalities of immune function were also observed; 18% of the patients had recent unexplained weight loss, 6% had lymphadenopathy, 8% had leukopenia, and 2% had lymphocytopenia. We conclude that both HBV and HAV were important infectious disease risks in these addicts, and that many evidenced deficiencies in immune function well before AIDS became a major public health concern.
Keywords: Adolescence Adult Age Factors Cohort Studies Communicable Diseases/*EPIDEMIOLOGY/TRANSMISSION Cross-Sectional Studies Female Heroin Dependence/COMPLICATIONS Human Incidence Kentucky Male Middle Age Narcotic Dependence/*EPIDEMIOLOGY Risk Factors Sex Factors *Street Drugs Substance Abuse, Intravenous/COMPLICATIONS/*EPIDEMIOLOGY Substance Dependence/*EPIDEMIOLOGY JOURNAL ARTICLE 900430
M9040595
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.